Wage gaps by gender, sector and year. by Mingming Li (502877)

“…<div><p>Although the Chinese government has implemented a variety of measures, the gender wage gap in 21^st century China has not decreased. …”

Expression of <i>TBC1D21</i> was decreased in teratozoospermia cases. by Ya-Yun Wang (175049)

Heatmaps of significant community cohesion differences between paired groups. by Yan He (116705)

Subjects:

Heatmaps of significant community disjointedness differences between paired groups. by Yan He (116705)

Subjects:

Effect sizes of nominally significant gene-set based tests in the DeCOI_EUR cohort. by Axel Schmidt (652713)

Subjects:

Prediction of cataract disease burden from 2022 to 2030 based on a Bayesian-age-period-cohort-model. by Lixia Lin (478155)

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”

Relative burden of diseases in Paraguay: DALYs. by Liz Paola Noguera Zayas (11636860)

Relative burden of diseases in Paraguay: ALEs. by Liz Paola Noguera Zayas (11636860)

Data Sheet 1_The changing burden of gout in adults aged 70 and above based on the global burden of disease 2019.pdf by Yang Yang (45629)

Datasheet3_Global burden of myocarditis and cardiomyopathy in children and prediction for 2035 based on the global burden of disease study 2019.csv by Hongjun Ba (12704864)

“…It was urgent to update the global incidence and mortality of childhood myocarditis and cardiomyopathy, and to predict the incidence rate of 2035 by the Global Burden of Disease database.</p>Methods<p>The Global Burden of Disease study data from 1990 to 2019 in 204 countries and territories were used to determine: global incidence and mortality rates of childhood myocarditis and cardiomyopathy from 0 to 19 by five age groups; relationship between sociodemographic index (SDI) and incidence and mortality rates by age group; and, based on an age-period-cohort model, the projected incidence of childhood myocarditis and cardiomyopathy for 2035.…”

Datasheet1_Global burden of myocarditis and cardiomyopathy in children and prediction for 2035 based on the global burden of disease study 2019.pdf by Hongjun Ba (12704864)

“…It was urgent to update the global incidence and mortality of childhood myocarditis and cardiomyopathy, and to predict the incidence rate of 2035 by the Global Burden of Disease database.</p>Methods<p>The Global Burden of Disease study data from 1990 to 2019 in 204 countries and territories were used to determine: global incidence and mortality rates of childhood myocarditis and cardiomyopathy from 0 to 19 by five age groups; relationship between sociodemographic index (SDI) and incidence and mortality rates by age group; and, based on an age-period-cohort model, the projected incidence of childhood myocarditis and cardiomyopathy for 2035.…”

Datasheet4_Global burden of myocarditis and cardiomyopathy in children and prediction for 2035 based on the global burden of disease study 2019.pdf by Hongjun Ba (12704864)

“…It was urgent to update the global incidence and mortality of childhood myocarditis and cardiomyopathy, and to predict the incidence rate of 2035 by the Global Burden of Disease database.</p>Methods<p>The Global Burden of Disease study data from 1990 to 2019 in 204 countries and territories were used to determine: global incidence and mortality rates of childhood myocarditis and cardiomyopathy from 0 to 19 by five age groups; relationship between sociodemographic index (SDI) and incidence and mortality rates by age group; and, based on an age-period-cohort model, the projected incidence of childhood myocarditis and cardiomyopathy for 2035.…”

Datasheet2_Global burden of myocarditis and cardiomyopathy in children and prediction for 2035 based on the global burden of disease study 2019.csv by Hongjun Ba (12704864)

“…It was urgent to update the global incidence and mortality of childhood myocarditis and cardiomyopathy, and to predict the incidence rate of 2035 by the Global Burden of Disease database.</p>Methods<p>The Global Burden of Disease study data from 1990 to 2019 in 204 countries and territories were used to determine: global incidence and mortality rates of childhood myocarditis and cardiomyopathy from 0 to 19 by five age groups; relationship between sociodemographic index (SDI) and incidence and mortality rates by age group; and, based on an age-period-cohort model, the projected incidence of childhood myocarditis and cardiomyopathy for 2035.…”

Presentation_1_A significant and persistent rise in the global burden of adolescent NAFLD and NASH estimated by BMI.pdf by Xiao-Yun Lin (11692305)

“…</p>Conclusion<p>The adolescent NAFLD/NASH prevalence increases year by year, and its burden varies significantly among different countries and regions. …”

Image_2_A significant and persistent rise in the global burden of adolescent NAFLD and NASH estimated by BMI.pdf by Xiao-Yun Lin (11692305)

“…</p>Conclusion<p>The adolescent NAFLD/NASH prevalence increases year by year, and its burden varies significantly among different countries and regions. …”

Image_1_A significant and persistent rise in the global burden of adolescent NAFLD and NASH estimated by BMI.pdf by Xiao-Yun Lin (11692305)

“…</p>Conclusion<p>The adolescent NAFLD/NASH prevalence increases year by year, and its burden varies significantly among different countries and regions. …”

Macroeconomic burden of NMHs over the period 2020–2050. by Maddalena Ferranna (9969446)

Subjects:

Base-case estimated number of patients categorised in different phenotypes and age groups and their base-case cost of management. by Siew Chin Ong (9314213)

Frontier Analysis Based on ASDR and SDI. by Guanghui Yu (423945)